Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Virus Diseases × Lamivudine × Lymphoid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma 3 Virus Diseases 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Lymphoma, Non-Hodgkin 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Hepatitis B 1

Interventions

Tenofovir 1 Lamivudine 1 Fluorescent Antibody Technique 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01528865 2016-03-11

Safety & Efficacy of Lamivudine & Tenofovir to Lower Plasma Level of Viral RNA in Lymphoma

University of Michigan Rogel Cancer Center

Phase 1/2 Withdrawn

Lymphoma, Virus Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡